BIO-TECHNE Corp vs Vertiv Holdings Co — how do they compare? BIO-TECHNE Corp trades at $71.63 (market cap $11.16B), while Vertiv Holdings Co trades at $305.58 (market cap $112.03B). The key difference: Vertiv Holdings Co is far larger — about 10× BIO-TECHNE Corp's market cap, and BIO-TECHNE Corp pays the higher dividend (0.45%). Which is the better fit depends on your goals.
| TECH | VRT | |
|---|---|---|
Market Cap | $11.16B | $112.03B |
Sector | Health | Technology |
52-Week High | $72.12 | $376.23 |
52-Week Low | $43.31 | $121.82 |
Enterprise Value | $11.24B | $112.80B |
Dividend Yield | 0.45% | 0.09% |
Trailing returns across standard periods
Latest headlines on both assets
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →Vertiv is a global leader in critical digital infrastructure, providing essential power, cooling, and IT management solutions for data centers, communication networks, and industrial facilities. As the primary provider of advanced thermal management and liquid cooling systems, Vertiv is a central player in the AI revolution, enabling the extreme density and power requirements of next-generation GPU-driven computing.
Read more on VRT →